Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries

Abstract Implementation of cervical cancer (CC) vaccination in Latin America is expected to reduce the high CC burden in those countries. But the efficiency of such vaccination programs in the region still remains unknown. This study assesses the cost-effectiveness and cost-utility of introducing va...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2009-09, Vol.27 (40), p.5519-5529
Hauptverfasser:	Colantonio, Lisandro, Gómez, Jorge A, Demarteau, Nadia, Standaert, Baudouin, Pichón-Rivière, Andrés, Augustovski, Federico
Format:	Artikel
Sprache:	eng
Schlagworte:	Allergy and Immunology Applied microbiology Biological and medical sciences Cancer Vaccines - economics Cervical cancer Cost-Benefit Analysis Cost-effectiveness analysis Female Fundamental and applied biological sciences. Psychology Human papillomavirus Humans Immunization Immunization Programs - economics Latin America Medical sciences Microbiology Miscellaneous Models, Economic Papillomavirus Infections - prevention & control Papillomavirus vaccines Papillomavirus Vaccines - economics Tumors Uterine cervical neoplasms Uterine Cervical Neoplasms - prevention & control Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract Implementation of cervical cancer (CC) vaccination in Latin America is expected to reduce the high CC burden in those countries. But the efficiency of such vaccination programs in the region still remains unknown. This study assesses the cost-effectiveness and cost-utility of introducing vaccination into the current CC disease management of five Latin American countries (Argentina, Brazil, Chile, Mexico, and Peru). The modelling results indicate that universal mass vaccination is cost-effective in the current health care setting of each country (
ISSN:	0264-410X 1873-2518
DOI:	10.1016/j.vaccine.2009.06.097